Cat.#: ACPP-1332
| Despition | GAD65 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1637 | Human NRN1 Protein, His (AC1637) | 2 µg | inquiry |
| ACPP-1829 | Human SNAPIN Protein (AC1829) | 10 µg | inquiry |
| ACPP-1186 | Olig2 Blocking Peptide (AC1186) | 250 µg | inquiry |
| ACPP-1802 | Human STAC Protein (AC1802) | 5 µg | inquiry |
| ACPP-1078 | Glutamate Receptor 1 Blocking Peptide (AC1078) | 250 µg | inquiry |
| ACPP-1526 | Human KCTD11 Protein (AC1526) | 2 µg | inquiry |
| ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
| ACPP-1359 | iNOS Blocking Peptide (AC1359) | 250 µg | inquiry |
| ACPP-1657 | Human CRCP Protein (AC1657) | 5 µg | inquiry |
| ACPP-1402 | Mouse CDNF Protein (AC1402) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.